Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma

Figure 5 Screening of the dominant differential bacterial communities in patients with hepatocellular carcinoma. A: The top 10 most dominant bacterial genera and their proportional presence in the three groups; B: Linear discriminant analysis effect size; C: Linear discriminant analysis score; D: Three representative bacterial genera with significant intergroup differences. The median is indicated by the dashed line, whereas the solid line denotes the mean. HCC: Hepatocellular carcinoma; HC: Healthy control; HCC12: Comprising patients with stage I and II hepatocellular carcinoma; HCC34: Comprising patients with stage III and IV hepatocellular carcinoma; LDA: Linear discriminant analysis.